Table 4 Sexual aid utilization following SBRT for prostate cancer
From: Potency preservation following stereotactic body radiation therapy for prostate cancer
Sexual aid: | Oral | Vacuum | Suppository | Injection |
|---|---|---|---|---|
Follow-up | ||||
Start | 36.1% | 1.0% | 0.0% | 0.0% |
3 mon | 35.8% | 1.1% | 1.1% | 0.0% |
6 mon | 37.9% | 2.3% | 0.0% | 0.0% |
9 mon | 39.1% | 2.3% | 0.0% | 1.1% |
12 mon | 40.0% | 4.4% | 1.1% | 0.0% |
18 mon | 45.0% | 3.80025 | 1.3% | 1.3% |
24 mon | 48.9% | 3.8% | 2.2% | 2.2% |